Enanta Pharmaceuticals (ENTA) Total Non-Current Liabilities (2012 - 2026)
Enanta Pharmaceuticals' Total Non-Current Liabilities came in at $107.51 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 5.6% from $101.81 million a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Total Non-Current Liabilities was $104.88 million, down 7.2% from FY2024.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
- Going back by fiscal year, Total Non-Current Liabilities was $113.06 million in FY2024 (+31.3%), $86.11 million in FY2023 (+60.6%), $53.62 million in FY2022 (+38.2%) and $38.8 million in FY2021 (+31.7%).
- The fiscal Q3 2026 figure represents the highest quarterly Total Non-Current Liabilities since fiscal Q4 2024.
- Year-over-year, Total Non-Current Liabilities increased in four of the last eight quarters, with growth averaging 5.6%.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q3 2023 (growth of 97.6%), and the weakest in fiscal Q1 2023 (a decline of 16.4%).
- Business Quant data shows ENTA's Total Non-Current Liabilities at $100.81 million (Q2 2026), $100.09 million (Q1 2026) and $104.88 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Enanta Pharmaceuticals | 327.55 Mn | -400.44 Mn | - | 107.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.23 Mn |
| Mar 31, 2026 | 100.53 Mn |
| Dec 31, 2025 | 99.82 Mn |
| Sep 30, 2025 | 104.62 Mn |
| Jun 30, 2025 | 101.56 Mn |
| Mar 31, 2025 | 103.83 Mn |
| Dec 31, 2024 | 106.85 Mn |
| Sep 30, 2024 | 112.83 Mn |
| Jun 30, 2024 | 107.79 Mn |
| Mar 31, 2024 | 99.44 Mn |
| Dec 31, 2023 | 84.35 Mn |
| Sep 30, 2023 | 85.45 Mn |
| Jun 30, 2023 | 91.95 Mn |
| Mar 31, 2023 | 56.66 Mn |
| Dec 31, 2022 | 46.28 Mn |
| Sep 30, 2022 | 53.62 Mn |
| Jun 30, 2022 | 46.75 Mn |
| Mar 31, 2022 | 47.36 Mn |
| Dec 31, 2021 | 55.35 Mn |
| Sep 30, 2021 | 38.80 Mn |
API Access
Enanta Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();